MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurobehavioral disorders"

  • 2024 International Congress

    Multifaceted Challenges in Multisystem Atrophy Management: Medication Sensitivity, Emotional Lability, and Increased Fall Risk

    G. Legerme, B. Carr, C. Rowan (Gainesville, USA)

    Objective: Multisystem atrophy (MSA) epitomizes a formidable quandary within neurological and geriatric disciplines, delineated by complex manifestations encompassing autonomic dysfunction, parkinsonism, and cerebellar ataxia. This…
  • 2024 International Congress

    Neuropsychiatric symptoms in sporadic Creutzfeldt-Jakob disease

    J. Zitser, S. Forner, K. Wong, J. Chengshi, J. Neuhaus, M. Kim, M. Hakimi, I. Allen, B. Miller, H. Rosen, K. Rankin, M. Geschwind (Tel Aviv, Israel)

    Objective: The objective of our study was to assess prospectively the neuropsychiatric features in sCJD (and their impact on caregivers) and compare them with five…
  • 2024 International Congress

    Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model

    S. -, V. Parcha (Dehardun, India)

    Objective: This research aims to assess whether Ibudilast (IBD), a phosphodiesterase IV (PDE IV) inhibitor, can mitigate the damage induced by 3-nitropropionic acid (3-NP) in…
  • 2024 International Congress

    Non-Motor Symptoms and Comorbidities in a Cohort of Puerto Rican Parkinson’s Disease: Do They Affect Severity and Progression?

    C. Serrano, K. Palermo, M. Morales, V. Wojna (San Juan, Puerto Rico)

    Objective: To describe for the first time the frequency of non-motor symptoms (NMS) and comorbidities in a group of idiopathic Parkinson disease (IPD) patients at…
  • 2024 International Congress

    Monitoring Progress: Use of the Behavioral Dyscontrol Scale-2 (BDS-2) in FXTAS (Fragile X-associated Tremor Ataxia Syndrome) Progression

    H. Hasan, A. Mokhtabad Amrei, E. Santos, H. Biag, A. Schneider, J. Wang, R. Hagerman (Sacramento, USA)

    Objective: To investigate the use of  the neuropsychological BDS-2 measures and its correlation with MRI findings and FXTAS stages[1] Background: Fragile X-associated Tremor Ataxia Syndrome…
  • 2024 International Congress

    Intensive Neurophysiological Rehabilitation System As a New Approach for Treatment of ASD Children

    T. Voloshyn (lviv, Ukraine)

    Objective: Rehabilitation of ASD children is the issue of the day as it's attributed to constantly increasing quantity of autistic children. Background: Existing rehabilitation approaches…
  • 2024 International Congress

    Patient Reported Outcomes of Using a Chaplain Service in a Huntington’s Disease Clinic

    C. Marshall, W. Aamodt, J. Klapper, P. Cinicola, N. Kleinberg, A. Lasker (Philadelphia, USA)

    Objective: To better understand and describe the impact of providing spiritual care, in the form of a chaplain service, to patients being seen in a…
  • 2024 International Congress

    Frontal Lobe Cortical Thickness and Volumetric Analysis in Parkinson’s Disease Based on Impulse Control Disorder

    R. Tripathi, D. Scarisbrick, S. Nkomboni, F. Isbaine, S. Miocinovic, D. Cobia, M. Haut (Atlanta, USA)

    Objective: Characterize differences in frontal cortical thickness and volumes in Parkinson’s disease based on impulse control disorder. Background: Impulse control disorder (ICD) is a debilitating…
  • 2024 International Congress

    The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease

    K. Yang, V. Quiroz, A. Tam, X. Villanueva, C. Amarales, D. Ebrahimi-Fakhari (Boston, USA)

    Objective: ​​​​​​Childhood-onset Huntington’s disease (HD) is a rare subset of HD with symptom-onset before the age of 18 years. We here detail the presenting movement…
  • 2023 International Congress

    Longitudinal association of mild behavioral impairment with cognitive decline in Parkinson’s disease

    G. Pinilla-Monsalve, M. Kibreab, N. Maarouf, I. Kathol, Z. Ismail, O. Monchi (Montréal, Canada)

    Objective: To analyze the cross-sectional and longitudinal association between mild behavioral impairment and cognitive impairment in Parkinson’s disease. Background: Cognitive impairment and neuropsychiatric symptoms (NPS)…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley